Sanxin pharmaceutical passes GMP Inspection
2011-06-24

With growing attention on food safety, the requirement on production level and management capacity is also increasing. June 20, after half a year’s careful preparation on technological change, advanced equipment import, software system setup and improvement, as well as personnel training, Tongwei Sanxin Pharmaceutical was prepared to welcome MOA veterinary drugs GMP experts for inspection.

Led by MOA veterinary drugs GMP expert Wang Hailiang, the inspection panel included director of Sichuan veterinary drugs Inspection Yang Songpei and other experts. General manager Cheng Gang and representatives of other departments guided experts for a 3-day thorough inspection on facilities, material management, production management, quality management, staffing, and sanitary control.

The inspection group gave high credit to the company’s workshop reform, production and quality management, and hoped that Sanxin could strictly carry out the standard management of Veterinary drug’s production and quality in its future management, and make more contribution to the healthy development of our country’s veterinary drug industry.

June 23, the two parties signed to confirm that Tongwei Sanxin passed the MOA veterinary drug GMP inspection.